Embera Neuro Therapeutics

Embera NeuroTherapeutics is a development-stage pharmaceutical company dedicated to developing therapies for smoking cessation and other addictions, with limited or no approved therapeutic options currently available. Embera is advancing a novel addiction treatment (EMB-001) that targets specific and complementary brain functions driving craving and relapse associated with these disorders, based on the groundbreaking discoveries of its scientific founders.